AICDA and infection: The design of the vaccine aimed to improve the nuclear abundance of AID and increase SHM via adjuvant, which may broaden the neutralization spectrum to prevent the infection of mutant SARS-CoV-2, such as E484K mutated virus strains that resist neutralizing antibodies after vaccine immunization.74,75